Report on Options for Safe Injection Sites, Berkeley Could Decriminalize LSD, More... (11/28/22)

Irish opposition parties are talking drug reform, the Congressional Research Service issues a report on how to get around legal proscriptions on safe injection sites, and more.

LSD in blotter acid form. There is a proposal in Berkeley to decriminalize it. (Creative Commons)

Berkeley Ponders Becoming First City to Decriminalize Not Just Natural Psychedelics But LSD, Too. A proposed ordinance to decriminalize natural psychedelic drugs such as magic mushrooms that has been under study in the city for the past three years may be expanded to include the synthetic hallucinogen LSD as well. A pair of Berkeley community health commissioners are promoting the move, saying that LSD meets the definition of a psychedelic and that "nobody deserves to go to jail for having a psychedelic experience." They have now rewritten the 2019 proposed ordinance to include LSD, prompting Decriminalize Nature, the original sponsors o the ordinance to now oppose it. The Community Health Commission is set to vote Tuesday on whether to refer the rewritten ordinance to the city council. At least 15 towns or cities across the US have passed natural psychedelic decriminalization or lowest priority ordinances, but Berkeley's would be the first to include LSD.

Harm Reduction

Congressional Research Service Provide Options for Allowing Safe Injection Sites The service, a nonpartisan agency that provides information on all kinds of issues to Congress, has issued a report highlighting the "uncertainty" of the federal government's position on safe injection sites, but also pointing out that the facilities could operate securely if Congress passed legislation barring the Justice Department from interfering with them, similar to actions it has taken to allow state medical marijuana laws to be implemented. The Trump administration Justice Department filed a lawsuit to block a Philadelphia safe injection site from opening, and the Biden Justice Department has so far shown much less enthusiasm for attacking the harm reduction facilities, but their fate remains uncertain. While the Biden administration is evaluating the legality of the facilities, CRS said: "Congress could resolve that uncertainty by enacting legislation. If Congress decided to allow supervised consumption sites to operate, it could consider the breadth of such authorization. One option would be to exempt supervised consumption sites from CSA control entirely" Or Congress could approve a temporary spending bill rider "to exempt from federal prosecution facilities operating in compliance with state and local law, as it has done with state-sanctioned medical marijuana activities." A third option "would be for Congress to impose specific registration requirements for supervised consumption sites under the CSA, as it has done for entities that administer medication-assisted treatment for opioid addiction," CRS continued. The report is Recent Developments in Opioid Regulation Under the Controlled Substances Act.

International

.Two opposition parties are championing major reforms in drug policy, albeit with two distinct proposals. People Before Profit's Gino Kenny has filed a private members' bill to decriminalize the possession of up to seven grams of marijuana, while the Labor Party is proposing a broader drug decriminalization bill. Kenny said marijuana prohibition is "a waste of time and resources" and that "there is a groundswell of opinion for a different narrative and a different status quo." The Labor Party, meanwhile is set to file its drug decriminalization bill Wednesday, with proponents arguing again that persecuting drug users was a waste of the police and the courts' time. But Minister of State at the Department of Health Frank Feighan said that the current government follows a drug strategy that embodies a "health-led rather than a criminal justice approach to drug use," it has no plans to decriminalize any drugs.